Previous studies have shown a positive correlation between the invasive capacity of tumor cells and their expression of LCN2, which promotes the epithelial–mesenchymal transition (EMT) and increases the motility and invasiveness of prostate cancer cells [5]. The gene discussed is LCN2; the disease is neoplasm.